Down regulation of prothrombinase by activated protein C during prothrombin activation

Paul Y Kim1, Michael E Nesheim

  • 1Department of Biochemistry, Queen's University, Kingston, Ontario, Canada.

Insights

Activated protein C (aPC) downregulates prothrombinase by inactivating factor Va (FVa). FXa and prothrombin protect FVa during this process, with protection effects being multiplicative.

Area of Science:

  • Biochemistry
  • Hematology
  • Enzymology

Background:

  • Activated protein C (aPC) is a key regulator of coagulation, primarily inactivating factor Va (FVa).
  • While FVa inactivation by aPC is well-studied, its inactivation within the prothrombinase complex during thrombin generation is less understood.

Purpose of the Study:

  • To investigate the inactivation of prothrombinase by aPC during prothrombin activation.
  • To determine the protective effects of FXa and prothrombin on FVa within the prothrombinase complex.

Main Methods:

  • Prothrombin activation was monitored using fluorescence assays with varying concentrations of aPC, FVa, and FXa.
  • Rate constants for prothrombinase and FVa inactivation were determined under different conditions, including the presence of protein S.

Main Results:

  • Prothrombinase inactivation by aPC followed pseudo first-order kinetics.
  • FVa is significantly protected (101-fold) from aPC inactivation when limiting in the prothrombinase complex, with FXa and prothrombin contributing multiplicatively to this protection.
  • When FVa is in excess, protection diminishes, indicating a reduced role for FXa.

Conclusions:

  • aPC downregulates FVa activity during prothrombin activation.
  • FXa and prothrombin provide multiplicative protection to FVa within the prothrombinase complex.
  • Protein S influences the rate of prothrombinase inactivation but does not abolish FVa protection.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...